Risk factors of perioperative complications and management with enhanced recovery after primary surgery in women with epithelial ovarian carcinoma in a single center
- Authors:
- Min Li
- Tianjiao Zhang
- Jing Zhu
- Yuebo Li
- Wenying Chen
- Yanhu Xie
- Wei Zhang
- Rongzhu Chen
- Wei Wei
- Guihong Wang
- Jiwei Qin
- Weidong Zhao
- Dabao Wu
- Zhen Shen
- Björn Nashan
- Ying Zhou
-
Affiliations: Department of Obstetrics and Gynecology, Core Facility Center, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, P.R. China, Department of Anesthesiology, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, P.R. China, Department of Anesthesiology, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, P.R. China, Department of Operative Nursing, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, P.R. China, Department of Imaging, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, P.R. China, Organ Transplantation Centre, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230036, P.R. China, Department of Obstetrics and Gynecology, Core Facility Center, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, P.R. China, Organ Transplantation Centre, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230036, P.R. China - Published online on: March 16, 2022 https://doi.org/10.3892/ol.2022.13274
- Article Number: 155
-
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Siegel RL, Miller KD and Jemal A: Cancer statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI | |
Huang Z, Zheng Y, Wen W, Wu C, Bao P, Wang C, Zhong W, Gao YT, Jin F, Xiang YB, et al: Incidence and mortality of gynaecological cancers: Secular trends in urban Shanghai, China over 40 years. Eur J Cancer. 63:1–10. 2016. View Article : Google Scholar : PubMed/NCBI | |
Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI | |
Høgdall E: Approaches to the detection of ovarian cancer. Scand J Clin Lab Invest Suppl. 245:S49–S53. 2016. View Article : Google Scholar : PubMed/NCBI | |
Winter WE III, Maxwell GL, Tian C, Carlson JW, Ozols RF, Rose PG, Markman M, Armstrong DK, Muggia F and McGuire WP; Gynecologic Oncology Group Study, : Prognostic factors for stage III epithelial ovarian cancer: A gynecologic oncology group study. J Clin Oncol. 25:3621–3627. 2007. View Article : Google Scholar : PubMed/NCBI | |
Chi DS, Eisenhauer EL, Lang J, Huh J, Haddad L, Abu-Rustum NR, Sonoda Y, Levine DA, Hensley M and Barakat RR: What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol. 103:559–564. 2006. View Article : Google Scholar : PubMed/NCBI | |
Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL and Montz FJ: Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis. J Clin Oncol. 20:1248–1259. 2002. View Article : Google Scholar : PubMed/NCBI | |
Kehoe SM, Eisenhauer EL and Chi DS: Upper abdominal surgical procedures: Liver mobilization and diaphragm peritonectomy/resection, splenectomy, and distal pancreatectomy. Gynecol Oncol. 111 (Suppl 2):S51–S55. 2008. View Article : Google Scholar : PubMed/NCBI | |
Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Poynor EA, Aghajanian C, Jarnagin WR, DeMatteo RP, D'Angelica MI, Barakat RR and Chi DS: The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecol Oncol. 103:1083–1090. 2006. View Article : Google Scholar : PubMed/NCBI | |
Hynninen J, Lavonius M, Oksa S, Grénman S, Carpén O and Auranen A: Is perioperative visual estimation of intra-abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy? Gynecol Oncol. 128:229–232. 2013. View Article : Google Scholar : PubMed/NCBI | |
Lv X, Cui S, Zhang X and Ren C: Efficacy and safety of neoadjuvant chemotherapy versus primary debulking surgery in patients with ovarian cancer: A meta-analysis. J Gynecol Oncol. 31:e122020. View Article : Google Scholar : PubMed/NCBI | |
Siesto G, Cavina R, Romano F and Vitobello D: Primary debulking surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A propensity-matched analysis. Am J Clin Oncol. 41:280–285. 2018. View Article : Google Scholar : PubMed/NCBI | |
Chen M, Chen Z, Xu M, Liu D, Liu T, He M and Yao S: Impact of the time interval from neoadjuvant chemotherapy to surgery in primary ovarian, tubal, and peritoneal cancer patients. J Cancer. 9:4087–4091. 2018. View Article : Google Scholar : PubMed/NCBI | |
Cole AL, Barber EL, Gogate A, Tran AQ and Wheeler SB: Economic analysis of neoadjuvant chemotherapy versus primary debulking surgery for advanced epithelial ovarian cancer using an aggressive surgical paradigm. Int J Gynecol Cancer. 28:1077–1084. 2018. View Article : Google Scholar : PubMed/NCBI | |
Eisenkop SM, Spirtos NM, Friedman RL, Lin W-CM, Pisani AL and Perticucci S: Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: A prospective study. Gynecol Oncol. 90:390–396. 2003. View Article : Google Scholar : PubMed/NCBI | |
Aletti GD, Dowdy SC, Gostout BS, Jones MB, Stanhope CR, Wilson TO, Podratz KC and Cliby WA: Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol. 107:77–85. 2006. View Article : Google Scholar : PubMed/NCBI | |
Chi DS, Zivanovic O, Levinson KL, Kolev V, Huh J, Dottino J, Gardner GJ, Leitao MM Jr, Levine DA, Sonoda Y, et al: The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas. Gynecol Oncol. 119:38–42. 2010. View Article : Google Scholar : PubMed/NCBI | |
Benedetti Panici P, Di Donato V, Fischetti M, Casorelli A, Perniola G, Musella A, Marchetti C, Palaia I, Berloco P and Muzii L: Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer: Analysis and management of complications in upper abdominal surgery. Gynecol Oncol. 137:406–411. 2015. View Article : Google Scholar : PubMed/NCBI | |
Tozzi R, Casarin J, Garruto-Campanile R, Majd HS and Morotti M: Morbidity and reversal rate of ileostomy after bowel resection during visceral-peritoneal debulking (VPD) in patients with stage IIIC-IV ovarian cancer. Gynecol Oncol. 148:74–78. 2018. View Article : Google Scholar : PubMed/NCBI | |
Phillips A, Sundar S, Singh K, Pounds R, Nevin J, Kehoe S, Balega J and Elattar A: The NICE classification for ‘Ultra-radical (extensive) surgery for advanced ovarian cancer’ guidance does not meaningfully predict postoperative complications: A cohort study. BJOG. 126:96–104. 2019. View Article : Google Scholar : PubMed/NCBI | |
Prat J; FIGO Committee on Gynecologic Oncology, : FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: Abridged republication. J Gynecol Oncol. 26:87–89. 2015. View Article : Google Scholar : PubMed/NCBI | |
Wu Y: Overweight and obesity in China. BMJ. 333:362–363. 2006. View Article : Google Scholar : PubMed/NCBI | |
Querleu D, Planchamp F, Chiva L, Fotopoulou C, Barton D, Cibula D, Aletti G, Carinelli S, Creutzberg C, Davidson B, et al: European society of gynaecological oncology (ESGO) guidelines for ovarian cancer surgery. Int J Gynecol Cancer. 27:1534–1542. 2017. View Article : Google Scholar : PubMed/NCBI | |
Nelson G, Altman AD, Nick A, Meyer LA, Ramirez PT, Achtari C, Antrobus J, Huang J, Scott M, Wijk L, et al: Guidelines for pre- and intra-operative care in gynecologic/oncology surgery: Enhanced recovery after surgery (ERAS®) society recommendations-part I. Gynecol Oncol. 140:313–322. 2016. View Article : Google Scholar : PubMed/NCBI | |
Nelson G, Altman AD, Nick A, Meyer LA, Ramirez PT, Achtari C, Antrobus J, Huang J, Scott M, Wijk L, et al: Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced recovery after surgery (ERAS®) society recommendations-part II. Gynecol Oncol. 140:323–332. 2016. View Article : Google Scholar : PubMed/NCBI | |
Tozzi R, Gubbala K, Majd HS and Campanile RG: Interval laparoscopic en-bloc resection of the pelvis (L-EnBRP) in patients with stage IIIC-IV ovarian cancer: Description of the technique and surgical outcomes. Gynecol Oncol. 142:477–483. 2016. View Article : Google Scholar : PubMed/NCBI | |
Tozzi R, Hardern K, Gubbala K, Garruto Campanile R and Soleymani Majd H: En-bloc resection of the pelvis (EnBRP) in patients with stage IIIC-IV ovarian cancer: A 10 steps standardised technique. Surgical and survival outcomes of primary vs interval surgery. Gynecol Oncol. 144:564–570. 2017. View Article : Google Scholar : PubMed/NCBI | |
Aletti GD, Dowdy SC, Podratz KC and Cliby WA: Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer. Am J Obstet Gynecol. 197:676.e1–e7. 2007. View Article : Google Scholar : PubMed/NCBI | |
Strasberg SM, Linehan DC and Hawkins WG: The accordion severity grading system of surgical complications. Ann Surg. 250:177–186. 2009. View Article : Google Scholar : PubMed/NCBI | |
Soleymani Majd H, Ferrari F, Manek S, Gubbala K, Campanile RG, Hardern K and Tozzi R: Diaphragmatic peritonectomy vs full thickness resection with pleurectomy during visceral-peritoneal debulking (VPD) in 100 consecutive patients with stage IIIC-IV ovarian cancer: A surgical-histological analysis. Gynecol Oncol. 140:430–435. 2016. View Article : Google Scholar : PubMed/NCBI | |
Rahbari NN, Weitz J, Hohenberger W, Heald RJ, Moran B, Ulrich A, Holm T, Wong WD, Tiret E, Moriya Y, et al: Definition and grading of anastomotic leakage following anterior resection of the rectum: A proposal by the international study group of rectal cancer. Surgery. 147:339–351. 2010. View Article : Google Scholar : PubMed/NCBI | |
Gessler B, Eriksson O and Angenete E: Diagnosis, treatment, and consequences of anastomotic leakage in colorectal surgery. Int J Colorectal Dis. 32:549–556. 2017. View Article : Google Scholar : PubMed/NCBI | |
Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, Allen P, Andersson R, Asbun HJ, Besselink MG, et al: The 2016 update of the international study group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years after. Surgery. 161:584–591. 2017. View Article : Google Scholar : PubMed/NCBI | |
Feldheiser A, Aziz O, Baldini G, Cox BP, Fearon KC, Feldman LS, Gan TJ, Kennedy RH, Ljungqvist O, Lobo DN, et al: Enhanced recovery after surgery (ERAS) for gastrointestinal surgery, part 2: Consensus statement for anaesthesia practice. Acta Anaesthesiol Scand. 60:289–334. 2016. View Article : Google Scholar : PubMed/NCBI | |
Scott MJ, Baldini G, Fearon KC, Feldheiser A, Feldman LS, Gan TJ, Ljungqvist O, Lobo DN, Rockall TA, Schricker T and Carli F: Enhanced recovery after surgery (ERAS) for gastrointestinal surgery, part 1: Pathophysiological considerations. Acta Anaesthesiol Scand. 59:1212–1231. 2015. View Article : Google Scholar : PubMed/NCBI | |
Labgaa I, Joliat GR, Kefleyesus A, Mantziari S, Schäfer M, Demartines N and Hübner M: Is postoperative decrease of serum albumin an early predictor of complications after major abdominal surgery? A prospective cohort study in a European centre. BMJ Open. 7:e0139662017. View Article : Google Scholar : PubMed/NCBI | |
Bisch S, Nelson G and Altman A: Impact of nutrition on enhanced recovery after surgery (ERAS) in gynecologic oncology. Nutrients. 11:10882019. View Article : Google Scholar : PubMed/NCBI | |
Barber EL, Boggess JF, Van Le L, Kim KH, Bae-Jump VL, Brewster WR, Soper JT and Gehrig PA: Association of preoperative thrombocytosis and leukocytosis with postoperative morbidity and mortality among patients with ovarian cancer. Obstet Gynecol. 126:1191–1197. 2015. View Article : Google Scholar : PubMed/NCBI | |
Lomnytska M, Karlsson E, Jonsdottir B, Lejon AM, Stålberg K, Poromaa IS, Silins I and Graf W: Peritoneal cancer index predicts severe complications after ovarian cancer surgery. Eur J Surg Oncol. 47:2915–2924. 2021. View Article : Google Scholar : PubMed/NCBI | |
Cham S, Chen L, St Clair CM, Hou JY, Tergas AI, Melamed A, Ananth CV, Neugut AI, Hershman DL and Wright JD: Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian cancer. Am J Obstet Gynecol. 220:571.e1–571.e8. 2019. View Article : Google Scholar : PubMed/NCBI | |
Ataseven B, du Bois A, Reinthaller A, Traut A, Heitz F, Aust S, Prader S, Polterauer S, Harter P and Grimm C: Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery. Gynecol Oncol. 138:560–565. 2015. View Article : Google Scholar : PubMed/NCBI | |
Ge LN and Wang F: Prognostic significance of preoperative serum albumin in epithelial ovarian cancer patients: A systematic review and dose-response meta-analysis of observational studies. Cancer Manag Res. 10:815–825. 2018. View Article : Google Scholar : PubMed/NCBI | |
Ayhan A, Günakan E, Alyazıcı İ, Haberal N, Altundağ Ö and Dursun P: The preoperative albumin level is an independent prognostic factor for optimally debulked epithelial ovarian cancer. Arch Gynecol Obstet. 296:989–995. 2017. View Article : Google Scholar : PubMed/NCBI | |
Asher V, Lee J and Bali A: Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer. Med Oncol. 29:2005–2009. 2012. View Article : Google Scholar : PubMed/NCBI | |
Coosemans AN, Baert T, D'Heygere V, Wouters R, DE Laet L, VAN Hoylandt A, Thirion G, Ceusters J, Laenen A, Vandecaveye V and Vergote I: Increased immunosuppression is related to increased amounts of ascites and inferior prognosis in ovarian cancer. Anticancer Res. 39:5953–5962. 2019. View Article : Google Scholar : PubMed/NCBI | |
Szender JB, Emmons T, Belliotti S, Dickson D, Khan A, Morrell K, Khan ANMN, Singel KL, Mayor PC, Moysich KB, et al: Impact of ascites volume on clinical outcomes in ovarian cancer: A cohort study. Gynecol Oncol. 146:491–497. 2017. View Article : Google Scholar : PubMed/NCBI | |
Günakan E, Tohma YA, Tunç M, Akıllı H, Şahin H and Ayhan A: Factors associated with surgical morbidity of primary debulking in epithelial ovarian cancer. Obstet Gynecol Sci. 63:64–71. 2020. View Article : Google Scholar : PubMed/NCBI | |
Bartl T, Schwameis R, Stift A, Bachleitner-Hofmann T, Reinthaller A, Grimm C and Polterauer S: Predictive and prognostic implication of bowel resections during primary cytoreductive surgery in advanced epithelial ovarian cancer. Int J Gynecol Cancer. 28:1664–1671. 2018. View Article : Google Scholar : PubMed/NCBI | |
Charnley RM: Effect of specialist decision-making on treatment strategies for colorectal liver metastases. Br J Surg. 2012.99:1263–1269. Br J Surg. 99:1269–1270. 2012. View Article : Google Scholar | |
Eng OS, Raoof M, Blakely AM, Yu X, Lee SJ, Han ES, Wakabayashi MT, Yuh B, Lee B and Dellinger TH: A collaborative surgical approach to upper and lower abdominal cytoreductive surgery in ovarian cancer. J Surg Oncol. 118:121–126. 2018. View Article : Google Scholar : PubMed/NCBI | |
Jones RP, Vauthey JN, Adam R, Rees M, Berry D, Jackson R, Grimes N, Fenwick SW, Poston GJ and Malik HZ: Effect of specialist decision-making on treatment strategies for colorectal liver metastases. Br J Surg. 99:1263–1269. 2012. View Article : Google Scholar : PubMed/NCBI | |
Aletti GD, Long HJ, Podratz KC and Cliby WA: Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer? Gynecol Oncol. 104:212–216. 2007. View Article : Google Scholar : PubMed/NCBI | |
Timmermans M, van der Aa MA, Lalisang RI, Witteveen PO, Van de Vijver KK, Kruitwagen RF and Sonke GS: Interval between debulking surgery and adjuvant chemotherapy is associated with overall survival in patients with advanced ovarian cancer. Gynecol Oncol. 150:446–450. 2018. View Article : Google Scholar : PubMed/NCBI | |
Alexander M, Beattie-Manning R, Blum R, Byrne J, Hornby C, Kearny C, Love N, McGlashan J, McKiernan S, Milar JL, et al: Guidelines for timely initiation of chemotherapy: A proposed framework for access to medical oncology and haematology cancer clinics and chemotherapy services. Intern Med J. 46:964–969. 2016. View Article : Google Scholar : PubMed/NCBI | |
Wijk L, Udumyan R, Pache B, Altman AD, Williams LL, Elias KM, McGee J, Wells T, Gramlich L, Holcomb K, et al: International validation of enhanced recovery after surgery society guidelines on enhanced recovery for gynecologic surgery. Am J Obstet Gynecol. 221:237.e1–237.e11. 2019. View Article : Google Scholar : PubMed/NCBI | |
Kay AH, Venn M, Urban R, Gray HJ and Goff B: Postoperative narcotic use in patients with ovarian cancer on an enhanced recovery after surgery (ERAS) pathway. Gynecol Oncol. 156:624–628. 2020. View Article : Google Scholar : PubMed/NCBI | |
Dowdy SC: Enhanced recovery after surgery for ovarian cancer. Clin Adv Hematol Oncol. 17:217–219. 2019.PubMed/NCBI | |
Damania R and Cocieru A: Impact of enhanced recovery after surgery protocols on postoperative morbidity and mortality in patients undergoing routine hepatectomy: Review of the current evidence. Ann Transl Med. 5:3412017. View Article : Google Scholar : PubMed/NCBI | |
Nelson G, Bakkum-Gamez J, Kalogera E, Glaser G, Altman A, Meyer LA, Taylor JS, Iniesta M, Lasala J, Mena G, et al: Guidelines for perioperative care in gynecologic/oncology: Enhanced recovery after surgery (ERAS) society recommendations-2019 update. Int J Gynecol Cancer. 29:651–668. 2019. View Article : Google Scholar : PubMed/NCBI | |
Lindemann K, Kok PS, Stockler M, Jaaback K and Brand A: Enhanced recovery after surgery for advanced ovarian cancer: A systematic review of interventions trialed. Int J Gynecol Cancer. 27:1274–1282. 2017. View Article : Google Scholar : PubMed/NCBI | |
Goulet D, Danilack V and Matteson KA: Enhanced recovery pathways for improving outcomes after minimally invasive gynecologic oncology surgery. Obstet Gynecol. 129:2072017. View Article : Google Scholar : PubMed/NCBI | |
Chapman JS, Roddy E, Ueda S, Brooks R, Chen LL and Chen LM: Enhanced recovery pathways for improving outcomes after minimally invasive gynecologic oncology surgery. Obstet Gynecol. 128:138–144. 2016. View Article : Google Scholar : PubMed/NCBI | |
Carter J: Enhanced recovery in gynecologic surgery. Obstet Gynecol. 122:13052013. View Article : Google Scholar : PubMed/NCBI | |
Kalogera E, Bakkum-Gamez JN, Jankowski CJ, Trabuco E, Lovely JK, Dhanorker S, Grubbs PL, Weaver AL, Haas LR, Borah BJ, et al: Enhanced recovery in gynecologic surgery. Obstet Gynecol. 122:319–328. 2013. View Article : Google Scholar : PubMed/NCBI | |
Rosa DD, Clamp A, Mullamitha S, Ton NC, Lau S, Byrd L, Clayton R, Slade RJ, Kitchener HC, Shanks JH, et al: The interval from surgery to chemotherapy in the treatment of advanced epithelial ovarian carcinoma. Eur J Surg Oncol. 32:588–591. 2006. View Article : Google Scholar : PubMed/NCBI | |
Cliby W, Dowdy S, Feitoza SS, Gostout BS and Podratz KC: Diaphragm resection for ovarian cancer: Technique and short-term complications. Gynecol Oncol. 94:655–660. 2004. View Article : Google Scholar : PubMed/NCBI | |
Ye S, He T, Liang S, Chen X, Wu X, Yang H and Xiang L: Diaphragmatic surgery and related complications in primary cytoreduction for advanced ovarian, tubal, and peritoneal carcinoma. BMC Cancer. 17:3172017. View Article : Google Scholar : PubMed/NCBI | |
Filippa N, Carricajo A, Grattard F, Fascia P, El Sayed F, Defilippis JP, Berthelot P and Aubert G: Outbreak of multidrug-resistant Klebsiella pneumoniae carrying qnrB1 and blaCTX-M15 in a French intensive care unit. Ann Intensive Care. 3:182013. View Article : Google Scholar : PubMed/NCBI | |
Rao SSC, Tan G, Abdulla H, Yu S, Larion S and Leelasinjaroen P: Does colectomy predispose to small intestinal bacterial (SIBO) and fungal overgrowth (SIFO)? Clin Transl Gastroenterol. 9:1462018. View Article : Google Scholar : PubMed/NCBI | |
Shichinohe T, Sasaki T, Kitashiro S, Morita T, Ono K, Senmaru N, Ikeda J, Kojima T, Kyogoku N, Yamada H, et al: Impact of elemental diet on early recovery after laparoscopic colectomy: Findings of a randomized controlled trial. Surg Today. 47:166–173. 2017. View Article : Google Scholar : PubMed/NCBI | |
Garcia-Granero A, Frasson M, Flor-Lorente B, Blanco F, Puga R, Carratalá A and Garcia-Granero E: Procalcitonin and C-reactive protein as early predictors of anastomotic leak in colorectal surgery: A prospective observational study. Dis Colon Rectum. 56:475–483. 2013. View Article : Google Scholar : PubMed/NCBI | |
Son JH, Kong TW, Paek J, Chang SJ and Ryu HS: Perioperative outcomes of extensive bowel resection during cytoreductive surgery in patients with advanced ovarian cancer. J Surg Oncol. 119:1011–1015. 2019. View Article : Google Scholar : PubMed/NCBI | |
Spetzler VN, Schepers M, Pinnschmidt HO, Fischer L, Nashan B and Li J: The incidence and severity of post-hepatectomy bile leaks is affected by surgical indications, preoperative chemotherapy, and surgical procedures. Hepatobiliary Surg Nutr. 8:101–110. 2019. View Article : Google Scholar : PubMed/NCBI | |
Nashan B and Citterio F: Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: A critical review of the literature. Transplantation. 94:547–561. 2012. View Article : Google Scholar : PubMed/NCBI | |
Sánchez-Iglesias JL, Gómez-Hidalgo NR, Pérez-Benavente A, Carbonell-Socias M, Manrique-Muñoz S, Serrano MP, Gutiérrez-Barceló P, Bradbury M, Nelson G and Gil-Moreno A: Importance of enhanced recovery after surgery (ERAS) protocol compliance for length of stay in ovarian cancer surgery. Ann Surg Oncol. 28:8979–8986. 2021. View Article : Google Scholar : PubMed/NCBI | |
Reuter S, Woelber L, Trepte CC, Perez D, Zapf A, Cevirme S, Mueller V, Schmalfeldt B and Jaeger A: The impact of enhanced recovery after surgery (ERAS) pathways with regard to perioperative outcome in patients with ovarian cancer. Arch Gynecol Obstet. Dec 27–2021.(Epub ahead of print). View Article : Google Scholar | |
Agarwal R, Rajanbabu A, Nitu PV, Goel G, Madhusudanan L and Unnikrishnan UG: A prospective study evaluating the impact of implementing the ERAS protocol on patients undergoing surgery for advanced ovarian cancer. Int J Gynecol Cancer. 29:605–612. 2019. View Article : Google Scholar : PubMed/NCBI | |
Meyer LA, Shi Q, Lasala J, Iniesta MD, Lin HK, Nick AM, Williams L, Sun C, Wang XS, Lu KH and Ramirez PT: Comparison of patient reported symptom burden on an enhanced recovery after surgery (ERAS) care pathway in patients with ovarian cancer undergoing primary vs interval tumor reductive surgery. Gynecol Oncol. 152:501–508. 2019. View Article : Google Scholar : PubMed/NCBI | |
Tankou JI, Foley O, Falzone M, Kalyanaraman R and Elias KM: Enhanced recovery after surgery protocols improve time to return to intended oncology treatment following interval cytoreductive surgery for advanced gynecologic cancers. Int J Gynecol Cancer. 31:1145–1153. 2021. View Article : Google Scholar : PubMed/NCBI | |
Duzgun O: Evaluation of enhanced recovery after following a surgical protocol for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Med Arch. 73:331–337. 2019. View Article : Google Scholar : PubMed/NCBI | |
Noh JJ, Kim MS and Lee YY: The implementation of enhanced recovery after surgery protocols in ovarian malignancy surgery. Gland Surg. 10:1182–1194. 2021. View Article : Google Scholar : PubMed/NCBI | |
Sánchez-Iglesias JL, Carbonell-Socias M, Pérez-Benavente MA, Monreal Clua S, Manrique-Muñoz S, García Gorriz M, Burgos-Peláez R, Segurola Gurrutxaga H, Pamies Serrano M, Pilar Gutiérrez-Barceló MD, et al: PROFAST: A randomised trial implementing enhanced recovery after surgery for highcomplexity advanced ovarian cancer surgery. Eur J Cancer. 136:149–158. 2020. View Article : Google Scholar : PubMed/NCBI | |
Bisch SP, Kooy J, Glaze S, Cameron A, Chu P, Ghatage P, Nation J, Nelson G and Fitzmaurice GM: Impact of transversus abdominis plane blocks versus non-steroidal anti-inflammatory on post-operative opioid use in ERAS ovarian cancer surgery. Int J Gynecol Cancer. 29:1372–1376. 2019. View Article : Google Scholar : PubMed/NCBI |